Masaomi Nangaku Selected Research

Biomarkers (Surrogate Marker)

10/2023	eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m2 in the J-DREAMS cohort.
10/2023	Application of urinary biomarkers for diagnosing acute kidney injury in critically ill patients without baseline renal function data.
10/2023	eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database.
1/2023	Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR).
10/2022	Snapshots of nascent RNA can validate different nephron segment responses in acute kidney injury: a step toward clinically useful biomarkers?
1/2022	Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics.
1/2022	Analysis of inflammatory cytokines and estimated glomerular filtration rate decline in Japanese patients with diabetic kidney disease: a pilot study.
1/2021	The Future of Nephrology and Public Health.
7/2020	Different Biomarker Kinetics in Critically Ill Patients with High Lactate Levels.
4/2018	Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaomi Nangaku Research Topics

Disease

113	Hypoxia (Hypoxemia) 03/2024 - 07/2003
94	Chronic Renal Insufficiency 05/2024 - 05/2006
61	Anemia 04/2024 - 01/2006
37	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 03/2004
35	Diabetic Nephropathies (Diabetic Nephropathy) 05/2024 - 01/2002
34	Proteinuria 10/2023 - 10/2001
30	Type 2 Diabetes Mellitus (MODY) 05/2024 - 04/2008
30	Neoplasms (Cancer) 12/2022 - 02/2008
27	Fibrosis (Cirrhosis) 07/2023 - 04/2002
26	Kidney Diseases (Kidney Disease) 04/2024 - 10/2008
21	Albuminuria 04/2024 - 08/2011
21	Inflammation (Inflammations) 09/2022 - 07/2006
19	Chronic Kidney Failure (Chronic Renal Failure) 10/2023 - 01/2002
16	Renal Insufficiency (Renal Failure) 04/2024 - 06/2004
16	Reperfusion Injury 01/2023 - 03/2004
15	Hypertension (High Blood Pressure) 01/2023 - 05/2003
13	Body Weight (Weight, Body) 04/2024 - 12/2005
13	Heart Failure 02/2024 - 10/2012
13	Ischemia 01/2023 - 03/2004
12	Atypical Hemolytic Uremic Syndrome 06/2023 - 01/2014
11	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2006
11	Infections 12/2021 - 02/2014
10	Thrombotic Microangiopathies 06/2023 - 10/2001
10	Diabetes Mellitus 01/2023 - 01/2015
9	Glomerulonephritis 03/2024 - 01/2002
9	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2017 - 12/2004
7	Sepsis (Septicemia) 07/2020 - 01/2014
6	IGA Glomerulonephritis (IGA Nephropathy) 04/2024 - 01/2002
6	COVID-19 12/2023 - 08/2020
6	Disease Progression 12/2023 - 10/2018
6	Hypophosphatemia 10/2023 - 01/2017
6	Critical Illness (Critically Ill) 10/2023 - 01/2016
6	Hyperglycemia 01/2021 - 12/2005
6	Obesity 01/2020 - 12/2005
6	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2018 - 05/2005
6	Nephritis 04/2015 - 01/2002
5	Osteomalacia 12/2023 - 06/2019
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 07/2012
5	Thrombosis (Thrombus) 01/2020 - 10/2001

Drug/Important Bio-Agent (IBA)

32	Prolyl-Hydroxylase InhibitorsIBA 03/2024 - 12/2007
27	Oxygen (Dioxygen)IBA 01/2022 - 01/2004
26	CreatinineIBA 04/2024 - 08/2011
26	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
22	Hemoglobins (Hemoglobin)IBA 03/2024 - 07/2006
22	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 05/2003
22	Erythropoietin FDA Link 01/2024 - 01/2006
21	HematinicsIBA 03/2024 - 08/2013
19	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2024 - 01/2006
17	Complement System Proteins (Complement)IBA 06/2023 - 01/2002
16	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2014
14	AlbuminsIBA 04/2024 - 03/2008
13	SodiumIBA 02/2024 - 09/2011
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2004
12	enarodustatIBA 04/2022 - 01/2019
11	empagliflozinIBA 04/2024 - 05/2019
11	IronIBA 11/2023 - 12/2005
11	Darbepoetin alfa (Aranesp)FDA Link 09/2023 - 01/2015
11	Transcription Factors (Transcription Factor)IBA 02/2021 - 11/2005
9	Blood Glucose (Blood Sugar)IBA 04/2024 - 08/2011
9	Advanced Glycation End ProductsIBA 09/2022 - 10/2002
9	Messenger RNA (mRNA)IBA 01/2019 - 04/2004
8	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2019
8	Histones (Histone)IBA 01/2023 - 01/2011
8	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2002
7	CytokinesIBA 01/2023 - 01/2011
7	GSK1278863IBA 12/2022 - 01/2017
7	ElementsIBA 11/2022 - 12/2004
7	EnzymesIBA 10/2019 - 02/2008
6	vadadustatIBA 03/2024 - 07/2020
6	bardoxolone methylIBA 11/2023 - 10/2019
6	Phosphates (Orthophosphate)IBA 10/2023 - 01/2017
6	SteroidsIBA 09/2023 - 10/2014
6	cobaltous chloride (cobalt(II)chloride)IBA 01/2023 - 11/2011
6	Fibroblast Growth Factor-23IBA 12/2022 - 01/2017
6	Insulin (Novolin)FDA Link 12/2022 - 05/2003
6	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 05/2003
6	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2022 - 09/2011
6	Lipocalin-2IBA 08/2020 - 11/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2013
6	CobaltIBA 01/2018 - 07/2003
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2023 - 07/2015
5	Uremic ToxinsIBA 01/2023 - 08/2010
5	esaxerenoneIBA 01/2023 - 01/2019
5	CalciumIBA 12/2022 - 05/2014
5	PotassiumIBA 11/2022 - 04/2017
5	Small Interfering RNA (siRNA)IBA 12/2020 - 08/2015
5	eculizumab FDA Link 04/2019 - 07/2016
5	Angiotensin IIIBA 01/2015 - 02/2004
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2024 - 05/2003
4	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2023 - 01/2015
4	AntibodiesIBA 06/2023 - 12/2017

Therapy/Procedure

56	Therapeutics 04/2024 - 04/2003
25	Renal Dialysis (Hemodialysis) 03/2024 - 04/2003
11	Peritoneal Dialysis 04/2024 - 09/2005
10	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2024 - 01/2019
7	Kidney Transplantation 04/2024 - 03/2004
6	Continuous Renal Replacement Therapy 10/2023 - 04/2015
6	Plasma Exchange 04/2019 - 07/2006
5	Catheters 12/2021 - 10/2020
4	Glycemic Control 02/2024 - 01/2010